HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

T 3762

structure in first source

Also Known As:

T-3762

Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        Fluoroquinolones: 5348
        T 3762: 2

Related Diseases

1.	Infections 05/01/1999 - "The results of this study suggest that, subject to confirmation by clinical trials, T-3762, in combination with an agent with reliable activity against anaerobic bacteria, is suitable as an empirical therapy of patients with obstetric and gynecological infections."
2.	Body Weight (Weight, Body) 11/01/1998 - "3. In the offspring, there were no effects on birth rate, viability, differentiation of external development, body weight, sensory function, emotionality, learning ability and reproductive performance in the T-3762 treated groups. " 11/01/1998 - "2. In the fetuses, there were no effects on the number of dead and live fetuses, sex ratio and body weight in the T-3762 treated groups. " 11/01/1998 - "1. In the dams, there were no effects on general condition, food intake, water intake and body weight in the T-3762 treated groups. "

Related Therapies and Procedures

1.	Therapeutics